Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
BMJ ; 378: o1660, 2022 07 07.
Article in English | MEDLINE | ID: mdl-35798367

Subject(s)
State Medicine , Humans
3.
BMJ ; 373: n1095, 2021 05 07.
Article in English | MEDLINE | ID: mdl-33962967
5.
Hypertension ; 77(3): 846-855, 2021 03 03.
Article in English | MEDLINE | ID: mdl-33325240

ABSTRACT

Hypertension has been identified as a risk factor for coronavirus disease 2019 (COVID-19) and associated adverse outcomes. This study examined the association between preinfection blood pressure (BP) control and COVID-19 outcomes using data from 460 general practices in England. Eligible patients were adults with hypertension who were tested or diagnosed with COVID-19. BP control was defined by the most recent BP reading within 24 months of the index date (January 1, 2020). BP was defined as controlled (<130/80 mm Hg), raised (130/80-139/89 mm Hg), stage 1 uncontrolled (140/90-159/99 mm Hg), or stage 2 uncontrolled (≥160/100 mm Hg). The primary outcome was death within 28 days of COVID-19 diagnosis. Secondary outcomes were COVID-19 diagnosis and COVID-19-related hospital admission. Multivariable logistic regression was used to examine the association between BP control and outcomes. Of the 45 418 patients (mean age, 67 years; 44.7% male) included, 11 950 (26.3%) had controlled BP. These patients were older, had more comorbidities, and had been diagnosed with hypertension for longer. A total of 4277 patients (9.4%) were diagnosed with COVID-19 and 877 died within 28 days. Individuals with stage 1 uncontrolled BP had lower odds of COVID-19 death (odds ratio, 0.76 [95% CI, 0.62-0.92]) compared with patients with well-controlled BP. There was no association between BP control and COVID-19 diagnosis or hospitalization. These findings suggest BP control may be associated with worse COVID-19 outcomes, possibly due to these patients having more advanced atherosclerosis and target organ damage. Such patients may need to consider adhering to stricter social distancing, to limit the impact of COVID-19 as future waves of the pandemic occur.


Subject(s)
Blood Pressure/drug effects , COVID-19/epidemiology , Hypertension/epidemiology , Pandemics , SARS-CoV-2 , Adult , Aged , Aged, 80 and over , Antihypertensive Agents/therapeutic use , Atherosclerosis/epidemiology , COVID-19/prevention & control , Comorbidity , England/epidemiology , Ethnicity/statistics & numerical data , Female , Follow-Up Studies , Hospitalization/statistics & numerical data , Humans , Hypertension/drug therapy , Logistic Models , Male , Middle Aged , Odds Ratio , Primary Health Care/statistics & numerical data , Retrospective Studies , Risk Factors , Severity of Illness Index , Survival Analysis , Treatment Outcome
7.
Med Hypotheses ; 85(5): 588-90, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26254502

ABSTRACT

Following observation of patients who have experienced psychological trauma, a model of recovery is described with implications for the efficiency and effectiveness of treatment.


Subject(s)
Models, Theoretical , Stress, Psychological/psychology , Humans
10.
Br J Gen Pract ; 58(549): 281; discussion 282, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18387238
SELECTION OF CITATIONS
SEARCH DETAIL
...